These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26723084)

  • 21. Normal liver sparing by proton beam therapy for hepatocellular carcinoma: Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy.
    Kim JY; Lim YK; Kim TH; Cho KH; Choi SH; Jeong H; Kim DW; Park JH; Shin DH; Lee SB; Kim SS; Kim JY; Kim DY; Park JW
    Acta Oncol; 2015 Nov; 54(10):1827-32. PubMed ID: 25765526
    [No Abstract]   [Full Text] [Related]  

  • 22. Ablative radiotherapy for colorectal liver metastases and intrahepatic cholangiocarcinoma.
    Schiff JP; D'Souza A; Henke LE
    Surgery; 2023 Jul; 174(1):108-112. PubMed ID: 36870808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors and prevention of radioembolization-induced liver disease.
    Gil-Alzugaray B; Chopitea A; Iñarrairaegui M; Bilbao JI; Rodriguez-Fraile M; Rodriguez J; Benito A; Dominguez I; D'Avola D; Herrero JI; Quiroga J; Prieto J; Sangro B
    Hepatology; 2013 Mar; 57(3):1078-87. PubMed ID: 23225191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Powerful radiotherapy for hepatocellular carcinoma.
    Matsuzaki Y
    J Gastroenterol Hepatol; 1999 Oct; 14(10):941-5. PubMed ID: 10530488
    [No Abstract]   [Full Text] [Related]  

  • 26. [Radiotherapy of malignant tumors of the liver].
    Ducreux M; Lartigau E; Eschwege F; Etienne JP
    Gastroenterol Clin Biol; 1995 Apr; 19(4):350-60. PubMed ID: 7672521
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of proton therapy in the treatment of gastrointestinal cancers: liver.
    Dionisi F; Ben-Josef E
    Cancer J; 2014; 20(6):371-7. PubMed ID: 25415681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computed tomography imaging assessment of postexternal beam radiation changes of the liver.
    Lock M; Malayeri AA; Mian OY; Mayr NA; Herman JM; Lo SS
    Future Oncol; 2016 Dec; 12(23):2729-2739. PubMed ID: 27576360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the use of protons and carbon ions for treatment.
    Uhl M; Herfarth K; Debus J
    Cancer J; 2014; 20(6):433-9. PubMed ID: 25415691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma: regarding Montemaggi et al., IJROBP 32:437; 1995.
    Mohan DS; Nori D
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):773-4. PubMed ID: 7558972
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
    J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton beam therapy for unresectable intrahepatic cholangiocarcinoma.
    Ohkawa A; Mizumoto M; Ishikawa H; Abei M; Fukuda K; Hashimoto T; Sakae T; Tsuboi K; Okumura T; Sakurai H
    J Gastroenterol Hepatol; 2015 May; 30(5):957-63. PubMed ID: 25376272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transarterial fiducial marker placement: a novel technique.
    Young S; Vogel J; Wiley S; Caridi J
    J Vasc Interv Radiol; 2013 May; 24(5):756-8. PubMed ID: 23622051
    [No Abstract]   [Full Text] [Related]  

  • 34. [Radiotherapy and combination radiochemotherapy in the treatment of primary cancers of the liver, pancreas and bile ducts].
    Eschwege F; Rougier P
    Acta Gastroenterol Belg; 1986; 49(2):175-81. PubMed ID: 3544636
    [No Abstract]   [Full Text] [Related]  

  • 35. Key considerations in reviewing "a comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma": the importance of scientific objective perspectives in clinical studies.
    Okumura T; Makishima H; Sakurai H
    Surg Today; 2020 Aug; 50(8):944-945. PubMed ID: 31965261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
    Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
    Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment modification of yttrium-90 radioembolization based on quantitative positron emission tomography/CT imaging.
    Chang TT; Bourgeois AC; Balius AM; Pasciak AS
    J Vasc Interv Radiol; 2013 Mar; 24(3):333-7. PubMed ID: 23433408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biliary tract carcinoma: surgery or irradiation?].
    Terpstra OT
    Ned Tijdschr Geneeskd; 1995 Jun; 139(22):1117-9. PubMed ID: 7540729
    [No Abstract]   [Full Text] [Related]  

  • 39. Is there a role for radiotherapy in the management of upper gastrointestinal malignancies?
    Abrams RA
    Surg Oncol Clin N Am; 2000 Jul; 9(3):525-38, ix. PubMed ID: 10853140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholangiocarcinoma and the role of radiation and chemotherapy.
    Price P
    Hepatogastroenterology; 2001; 48(37):51-2. PubMed ID: 11268997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.